IMIDOCARB USE IN ANIMALS

Abstract

Imidocarb dipropionate is a carbanilide derivative antiprotozoan drug. The drug is approved for use in animals for the treatment of tick-borne transmitted babesiosis (piroplasmosis) and anaplasmosis. However, its effectiveness against some other microorganisms transmitted by ticks has also been investigated. Although cattle, horses, donkeys, mules, dogs and sheep are defined as target species, they can also be used in other domestic and wild animals. Although it is recommended to use the drug as a single dose, it can be applied 2-3 days later if necessary. The therapeutic index of the drug is narrow, and attention should be paid to the dosage regimen. In this review, it could be tried to give information about the use of imidocarb in animal species, its success in treatment and its side effects.

Keywords

• Imidocarb
• Animal species
• Usage

HAYVANLARDA İMIDOKARB KULLANIMI

Abstract

İmidokarb dipropionat karbanilid türevi antiprotozoon ilaçtır. İlacın hayvanlarda kullanımı kenelerle nakledilen babesiosis (piroplasmosis) ve anaplasmosis tedavisinde onaylanmıştır. Ancak kenelerle nakledilen diğer bazı mikroorganizmalara etkinliği de araştırılmıştır. Sığır, at, eşek, katır, köpek ve koyunlar hedef türler olarak tanımlanmakla birlikte, diğer evcil ve yabani hayvanlarda da kullanılabilmektedir. İlacın tek doz olarak kullanımı önerilmekle birlikte, gerektiğinde 2-3 gün sonra uygulama yapılabilir. İlacın terapötik indeksi dardır ve dozaj rejimine dikkat edilmelidir. Bu derlemede imidokarbın hayvan türlerinde kullanımı, tedavide başarısı ve yan etkileri hakkında bilgiler verilmeye çalışılmıştır.

Keywords

• Imidocarb
• Hayvan türleri
• Kullanımı

References

1. Abdullah, A. S., Sheikh-Omar, A. R., Baggot, J. D. & Zamri, M. (1984). Adverse effects of imidocarb dipropionate (Imizol®) in a dog. Veterinary Research Communications, 8 (1), 55-59.
2. Abdullah, A. S. & Baggot, J. D. (1986). Influence of induced disease states on the disposition kinetics of imidocarb in goats. Journal of Veterinary Pharmacology and Therapeutics, 9 (2), 192-197.
3. Abutarbush, S. M., Alfaqeeh, S. M., Mustafa, G., Qura’n, L. & Al-Majali, A. M. (2013). Evaluation of the use of atropine sulfate, a combination of butylscopolammonium bromide and metamizole sodium, and flunixin meglumine to ameliorate clinical adverse effects of imidocarb dipropionate in horses. American Journal of Veterinary Research, 74 (11), 1404-1408.
4. Adam, M., Pikalo, J., Snyder, A., Steinrigl, A., Köller, G. & Schusser, GF. (2017). Equine Piroplasmosis – a case of severe Babesia caballi infection associated with acute renal failure. Berliner und Münchener Tierärztliche Wochenschrift, 130 (3), 111-118.
5. Adams, L. G., Corrier, D. E. & Williams, J. D. (1980). A study of the toxicity of imidocarb dipropionate in cattle. Research in Veterinary Science, 28 (2), 172-177.
6. Adams, L. G. (1981). Clinicopathological aspects of imidocarb dipropionate toxicity in horses. Research in Veterinary Science, 31 (1), 54-61.
7. Afifi, N. A., Shihata, I. M., El-Zorba, H. Y. & Ismail, I. M. (2014). Effect of Imidocarb dipropionate on the immune response to Foot and Mouth Disease vaccine in healthy and anaplasmosis-infected calves. Veterinary World, 7 (3),162-167.
8. Al Izzi, S., Martin, D. S., Chan, R. Y. & Leutenegger, C. M. (2013). Babesia canis vogeli, Ehrlichia canis, and Anaplasma platys infection in a dog. Veterinary Clinical Pathology, 42 (4), 471-475.

9. Ali, B. H., Hassan, T., Suliman, H. B. & Abdelsalam, E. B. (1985). Some effects of imidocarb in goats (Abstract). Veterinary and Human Toxicology, 27 (6), 477-480.
10. Aliu, Y. O., Davis Jr, R. H., Camp, B. J. & Kuttler, K. L. (1977). Absorption, distribution, and excretion of imidocarb dipropionate in sheep. American Journal of Veterinary Research, 38 (12), 2001-2007.
11. Allison, R. W., Yeagley, T. J., Levis, K. & Reichard, M. V. (2011). Babesia canis rossi infection in a Texas dog. Veterinary Clinical Pathology, 40 (3), 345-350.
12. Atif, F. A., Khan, M. S., Khan, M. A., Ashraf, M. & Avais, M. (2012). Chemotherapeutic efficacy of oxytetracycline, enrofloxacin and imidocarb for the elimination of persistent Anaplasma marginale infection in naturally infected sahiwal cattle. Pakistan Journal of Zoology, 44 (2), 449-456.
13. Baneth, G. (2018). Antiprotozoal treatment of canine babesiosis. Veterinary Parasitology, 254, 58-63.
14. Barre, N., Happold, J., Delathiere, J.M., Desoutter, D., Salery, M., de Vos, A., Marchal, C., Perrot, R., Grailles, M. & Mortelecque, A. (2011). A campaign to eradicate bovine babesiosis from New Caledonia. Ticks Tick-borne Diseases, 2 (1):55-61.
15. Bartlett, S. L., Abou-Madi, N., Messick, J. B., Birkenheuer, A. & Kollias, G. V. (2009). Diagnosis and treatment of Babesia odocoilei in captive reindeer (Rangifer tarandus tarandus) and recognition of three novel host species. Journal of Zoo and Wildlife Medicine, 40 (1), 152-159.
16. Basso, W., Görner, D., Globokar, M., Keidel, A. & Pantchev, N. (2019). First autochthonous case of clinical Hepatozoon felis infection in a domestic cat in Central Europe. Parasitology International, 72, 101945.
17. Bastos, T. S. A., Faria, A. M., Cavalcante, A. S. A., Madrid, D. M. C., Zapa, D. M. B., Nicaretta, J. E., Cruvinel, L. B., Heller, L. M., Couto, L. F. M., Soares, V. E., Cadioli, F. A. & Lopes, W. D. Z. (2020). Comparison of therapeutic efficacy of different drugs against Trypanosoma vivax on experimentally infected cattle. Preventive Veterinary Medicine, 181, 105040.
18. Belloli, C., Crescenzo, G., Lai, O., Carofiglio, V., Marang, O. & Ormas, P. (2002). Pharmacokinetics of imidocarb dipropionate in horses after intramuscular administration. Equine Veterinary Journal, 34 (6), 625-629.
19. Belloli, C., Lai, O. R., Ormas, P., Zizzadoro, C., Sasso, G. & Crescenzo, G. (2006). Pharmacokinetics and mammary elimination of imidocarb in sheep and goats. Journal of Dairy Science, 89 (7), 2465-2472.
20. Borisov, B., Marinov, G., Panayotov, P. & Zlateva, N. (2017). Vector born diseases in dogs–Dirofilariosis and Anaplasmosis. A clinical study. Tradition and modernity in Veterinary Medicine, 2 (1), 2.
21. Borras, P., Salvador, F., Rinaldi, V., Armitano, R., Farber, M., Sanchez, R., Mori, L. & Guillemi, E. (2020). Use of molecular tools for the diagnosis of rangeliosis by Rangelia vitalii in Argentina: A case report. Veterinary Parasitology: Regional Studies and Reports, 21, 100426.
22. Butler, C. M., Nijhof, A. M., Van der Kolk, J. H., De Haseth, O. B., Taoufik, A., Jongejan, F. & Houwers, D. J. (2008). Repeated high dose imidocarb dipropionate treatment did not eliminate Babesia caballi from naturally infected horses as determined by PCR-reverse line blot hybridization. Veterinary Parasitology, 151 (2-4), 320-322.
23. Brandão, L. P., Hagiwara, M. K. & Myiashiro, S. I. (2003). Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate. Veterinary Parasitology, 114 (4), 253-265.
24. Brüning, A. (1996). Equine piroplasmosis an update on diagnosis, treatment and prevention. British Veterinary Journal, 152 (2), 139-151.
25. Carli, E., Trotta, M., Bianchi, E., Furlanello, T., Caldin, M., Pietrobelli, M. & Solano-Gallego, L. (2014). Cytauxzoon sp. infection in two free ranging young cats: clinicopathological findings, therapy and follow up. Türkiye Parazitoloji Dergisi, 38 (3), 185.
26. Checa, R., Montoya, A., Ortega, N., Gonzalez-Fraga, J. L., Bartolome, A., Galvez, R., Marino, V. & Miro, G. (2017). Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm. Parasites & Vectors, 10 (1), 1-12.
27. Collett, M. G. (2000). Survey of canine babesiosis in South Africa. Journal of the South African Veterinary Association, 71 (3), 180-186.
28. Copat, B., Bastiani, P. V., Jaconi, F. C., Damarem, W. W., Streck, A. P., de Oliveira, E. C., Sonne, L. & França, R. T. (2019). Presentation of hemolytic and hemorrhagic rangeliosis in Cerdocyon thous. Ticks and tick-borne diseases, 10 (3), 690-693.
29. Corrier, D. E. & Adams, L. G. (1976). Clinical, histologic, and histochemical study of imidocarb dipropionate toxicosis in goats. Am J Vet Res, 37, 811-816.
30. Coşkun, D. &Yazar, E. (2019). Kemoterapi, in: Manda El Kitabı, Eds: Dik B, Avcı O, Güneş Tıp Kitabevleri, Ankara, Türkiye, pp: 211-260.
31. Da Silva, A. S., França, R. T., Soares, J. F., Girotto, A., Monteiro, S. G., Labruna, M. B. & Lopes, S. T. (2011). Report of a clinical case of dog infected by Hepatozoon canis in Southern Brazil. Comparative Clinical Pathology, 20 (6), 669-672.
32. De Bonis, A., Colombo, M., Terragni, R., Bacci, B., Morelli, S., Grillini, M. & Vignoli, M. (2021). Potential role of Hepatozoon canis in a fatal systemic disease in a puppy. Pathogens, 10 (9), 1193.
33. De Tommasi, A. S., Giannelli, A., de Caprariis, D., Ramos, R. A. N., Di Paola, G., Crescenzo, G., Dantas-Torres, F., Baneth, G. & Otranto, D. (2014). Failure of imidocarb dipropionate and toltrazuril/emodepside plus clindamycin in treating Hepatozoon canis infection. Veterinary Parasitology, 200 (3-4), 242-245.
34. Dirks, E., de Heus, P., Joachim, A., Cavalleri, J. M., Schwendenwein, I., Melchert, M. & Fuehrer, H. P. (2021). First case of autochthonous equine theileriosis in Austria. Pathogens, 10 (3), 298.
35. Donnellan, C. M. B., Page, P. C., Nurton, J. P., van den Berg, J. S. & Guthrie, A. J. (2013). Comparison of glycopyrrolate and atropine in ameliorating the adverse effects of imidocarb dipropionate in horses. Equine Veterinary Journal, 45 (5), 625-629.
36. Doyle, R. L., Fritzen, A., Bottari, N. B., Alves, M. S., da Silva, A. D., Morsch, V. M., Schetinger, M. R. C., Martins, J. R., Santos, J. S., Machado, G. & da Silva, A. S. (2016). Imidocarb dipropionate in the treatment of Anaplasma marginale in cattle: Effects on enzymes of the antioxidant, cholinergic, and adenosinergic systems. Microbial Pathogenesis, 97, 226-230.
37. Ekici, O. D. & Işık, N. (2011). Antipataziter tedavi, in: At, Ed: Yazar E, Nobel tıp kitabevleri, İstanbul, Türkiye, pp:77-86.
38. Ekici, O. D. & Isik, N. (2012). Alterations of blood parameters after intramuscular administration of imidocarb in healthy lambs. Drug and Chemical Toxicology, 35 (2), 162-166.
39. Ekici O. D. (2021). Protozoon hastalıkları, in: Merkep (Eşek) El Kitabı, Eds: Çizmeci SÜ, Alaşahan S, Nobel yayınevi, Ankara, Türkiye, pp:125-135.
40. Eddlestone, S. M., Neer, T. M., Gaunt, S. D., Corstvet, R., Gill, A., Hosgood, G., Hegarty, B. & Breitschwerdt, E. B. (2006). Failure of imidocarb dipropionate to clear experimentally induced Ehrlichia canis infection in dogs. Journal of Veterinary Internal Medicine, 20 (4), 840-844.
41. EMA. (2001). https://www.ema.europa.eu/en/documents/mrl-report/imidocarb-summary-report-2-committee-veterinary-medicinal-products_en.pdf, Accessed at:22.05.22.
42. Ememe, M. U., Onyegbula, O., Egwuogu, F. C., Nlebedum, C. U. & Ogbu, C. C. (2018). Babesia caballi infection in a 6-month-old colt. Sokoto Journal of Veterinary Sciences, 16 (1), 102-106.
43. Esmaeilnejad, B., Dalir-Naghadeh, B., Tavassoli, M., Asri-Rezaei, S., Mahmoudi, S., Rajabi, S., Aligolzadeh, A., Akbari, H. & Morvaridi, A. (2021). Assessment of hepatic oxidative damage, paraoxonase-1 activity, and lipid profile in cattle naturally infected with Babesia bigemina. Tropical Animal Health and Production, 53 (2), 1-8.
44. França, R. T., Da Silva, A. S., Paim, F. C., Costa, M. M., Soares, J. F., Mazzanti, C. M. & dos Anjos Lopes, S. T. (2010). Rangelia vitalli in dogs in southern Brazil. Comparative Clinical Pathology, 19 (4), 383-387.
45. Gray, J. S. & Potgieter, F. T. (1981). The retention of Babesia bigemina infections by Boophilus decoloratus exposed to imidocarb dipropionate during engorgement. Onderstepoort Journal of Veterinary Research, 48 (4), 225-227.
46. Ionita, M., Nicorescu, I. M., Pfister, K. & Mitrea, I. L. (2018). Parasitological and molecular diagnostic of a clinical Babesia caballi outbreak in Southern Romania. Parasitology Research, 117 (7), 2333-2339.
47. Irizarry‐Rovira, A. R., Stephens, J., Christian, J., Kjemtrup, A., DeNicola, D. B., Widmer, W. R. & Conrad, P. A. (2001). Babesia gibsoni infection in a dog from Indiana. Veterinary Clinical Pathology, 30 (4), 180-188.
48. Irwin, P. J. (2009). Canine babesiosis: from molecular taxonomy to control. Parasites & Vectors, 2 (1), 1-9.
49. Irwin, P. J. & Hutchinson, G. W. (1991). Clinical and pathological findings of Babesia infection in dogs. Australian Veterinary Journal, 68 (6), 204-209.
50. Jiménez-Meléndez, A., Rico-San Román, L., Hemphill, A., Balmer, V., Ortega-Mora, L. M. & Álvarez-García, G. (2018). Repurposing of commercially available anti-coccidials identifies diclazuril and decoquinate as potential therapeutic candidates against Besnoitia besnoiti infection. Veterinary Parasitology, 261, 77-85.
51. Kock, N. & Kelly, P. (1991). Massive hepatic necrosis associated with accidental imidocarb dipropionate toxicosis in a dog. Journal of Comparative Pathology, 104 (1), 113-116.
52. Kumar, S., Gupta, A. K., Pal, Y. & Dwivedi, S. K. (2003). In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys. Journal of Veterinary Medical Science, 6 5(11):1171-1177.
53. Legroux, J. P., Halos, L., Rene-Martellet, M., Servonnet, M., Pingret, J. L., Bourdoiseau, G., Baneth, G. & Chabanne, L. (2017). First clinical case report of Cytauxzoon sp. infection in a domestic cat in France. BMC Veterinary Research, 13 (1), 1-7.
54. Lewis, B. D., Penzhorn, B. L. & Volkmann, D. H. (1999). Could treatment of pregnant mares prevent abortions due to equine piroplasmosis? Journal of the South African Veterinary Association, 70 (2), 90-91.
55. Lilliehöök, I., Tvedten, H. W., Pettersson, H. K. & Baneth, G. (2019). Hepatozoon canis infection causing a strong monocytosis with intra‐monocytic gamonts and leading to erroneous leukocyte determinations. Veterinary Clinical Pathology, 48 (3), 435-440.
56. Marchetti, V., Lubas, G., Baneth, G., Modenato, M. & Mancianti, F. (2009). Hepatozoonosis in a dog with skeletal involvement and meningoencephalomyelitis. Veterinary Clinical Pathology, 38 (1), 121-125.
57. Marco, I., Velarde, R., Castellà, J., Ferrer, D. & Lavı́n, S. (2000). Presumptive Babesia ovis infection in a spanish ibex (Capra pyrenaica). Veterinary Parasitology, 87 (2-3), 217-221.
58. Máthé, A., Vörös, K., Papp, L. & Reiczigel, J. (2006). Clinical manifestations of canine babesiosis in Hungary (63 cases). Acta Veterinaria Hungarica, 54 (3), 367-385.
59. Máthé, A., Dobos-Kovács, M. & Vörös, K. (2007). Histological and ultrastructural studies of renal lesions in Babesia canis infected dogs treated with imidocarb. Acta Veterinaria Hungarica, 55 (4), 511-523.
60. McHardy, N., Woollon, R. M., Clampitt, R. B., James, J. A. & Crawley, R. J. (1986). Efficacy, toxicity and metabolism of imidocarb dipropionate in the treatment of Babesia ovis infection in sheep. Research in Veterinary Science, 41 (1), 14-20.
61. McInnes, E. F., Stewart, C. G., Penzhorn, B. L. & Meltzer, D. G. (1991). An outbreak of babesiosis in imported sable antelope (Hippotragus niger) (abstract). Journal of the South African Veterinary Association, 62 (1), 30-32.
62. Mehlhorn, H. & Schein, E. (1998). Redescription of Babesia equi Laveran, 1901 as Theileria equi Mehlhorn, Schein 1998. Parasitology Research, 84 (6), 467-475.
63. Meyer, C., Guthrie, A. J. & Stevens, K. B. (2005). Clinical and clinicopathological changes in 6 healthy ponies following intramuscular administration of multiple doses of imidocarb dipropionate. Journal of the South African Veterinary Association, 76 (1), 26-32.
64. Milnes, E.L., Delnatte, P., Woodbury, M., Hering, A., Lee, S., Smith, D.A., Nemeth, N.M., Gu, Y., Gehring, R. & Johnson, R. (2020). Pharmacokinetics of imidocarb dipropionate in white-tailed deer (Odocoileus virginianus) after single intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics, 43 (1), 33-37.
65. Mishra, A. K. & Sharma, N. N. (1979). Comparative efficacy of drugs in bovine anaplasmosis. Tropical Animal Health and Production, 11 (1), 222-226.
66. MSD. (2022). https://vetrehberi.com/imidovil/, Accessed at: 19.05.22.
67. Mylonakis, M. E., Koutinas, A. F., Baneth, G., Polizopoulou, Z. & Fytianou, A. (2004). Mixed Ehrlichia canis, Hepatozoon canis, and presumptive Anaplasma phagocytophilum infection in a dog. Veterinary Clinical Pathology, 33 (4), 249-251.
68. Naor, A. W., Lindemann, D. M., Schreeg, M. E., Marr, H. S., Birkenheuer, A. J., Carpenter, J. W. & Ryseff, J. K. (2019). Clinical, morphological, and molecular characterization of an undetermined Babesia species in a maned wolf (Chrysocyon brachyurus). Ticks and tick-borne diseases, 10 (1), 124-126.
69. Novacco, M., Hofmann-Lehmann, R., Grimm, F., Meli, M. L. & Stirn, M. (2019). Fatal acute babesiosis associated with Babesia venatorum infection (Babesia sp. EU1) in a captive reindeer calf in Switzerland. Veterinary Parasitology: Regional Studies and Reports, 18, 100336.
70. Olukunle, J. O., Oyedoyin, C. T., Jacobs, E. B., Adeleye, E. O., Omobowale, T. O. & Arowolo, R. O. A. (2018). Comparative assessment of the effect of diminazene aceturate and imidocarb dipropionate on haematology and serum biochemical parameters of apparently healthy Nigerian dogs. Egyptian Journal of Veterinary Sciences, 49 (2), 75-81.
71. Panghal, R. S., Rana, R. D. & Vinod, K. (2009). Effects of imidocarb on cholinesterase activity and grossly observable behaviour in dogs. Haryana Veterinarian, 48, 26-28.
72. Pasa, S., Voyvoda, H., Karagenc, T., Atasoy, A. & Gazyagci, S. (2011). Failure of combination therapy with imidocarb dipropionate and toltrazuril to clear Hepatozoon canis infection in dogs. Parasitology Research, 109 (3), 919-926.
73. Phair, K. A., Carpenter, J. W., Smee, N., Myers, C. B. & Pohlman, L. M. (2012). Severe anemia caused by babesiosis in a maned wolf (Chrysocyon brachyurus). Journal of Zoo and Wildlife Medicine, 43 (1), 162-167.
74. Price, J. E. & Dolan, T. T. (1980). A comparison of the efficacy of imidocarb dipropionate and tetracycline hydrochloride in the treatment of canine ehrlichiosis. The Veterinary Record, 107 (12), 275-277.
75. Radyuk, E. & Karan, L. (2020). A case of Babesia vulpes infection in a dog in Russia. Veterinary Parasitology: Regional Studies and Reports, 22, 100467.
76. Rashid, A., Mubarak, A. & Hussain, A. (2009). Babesiosis in equines in Pakistan: a clinical report. Vet Ital, 45 (3), 391-5.
77. Şahal, M., Kar, S., Gazyağcı, S. & Aktaş M. S. (2009). Babesiosis in a cattle during winter season and its treatment with imidocarb dipropionate. Atatürk Üniversitesi Veteriner Bilimleri Dergisi, 4 (3), 191-195.
78. Sainz, A., Tesouro, M. A., Amusategui, I., Rodriguez, F., Mazzucchelli, F. & Rodriguez, M. (2000). Prospective comparative study of 3 treatment protocols using doxycycline or imidocarb dipropionate in dogs with naturally occurring ehrlichiosis. Journal of Veterinary Internal Medicine, 14 (2), 134-139.
79. Sarli, M., Novoa, M. B., Mazzucco, M. N., Morel, N., Primo, M. E., de Echaide, S. T. & Echaide, I. E. (2021). Efficacy of long-acting oxytetracycline and imidocarb dipropionate for the chemosterilization of Anaplasma marginale in experimentally infected carrier cattle in Argentina. Veterinary Parasitology: Regional Studies and Reports, 23, 100513.
80. Sasanelli, M., Paradies, P., Greco, B., Eyal, O., Zaza, V. & Baneth, G. (2010). Failure of imidocarb dipropionate to eliminate Hepatozoon canis in naturally infected dogs based on parasitological and molecular evaluation methods. Veterinary Parasitology, 171 (3-4), 194-199.
81. Sato, M., Veir, J. K., Shropshire, S. B. & Lappin, M. R. (2020). Ehrlichia canis in dogs experimentally infected, treated, and then immune suppressed during the acute or subclinical phases. Journal of Veterinary Internal Medicine, 34 (3), 1214-1221.
82. Schwint, O. N., Ueti, M. W., Palmer, G. H., Kappmeyer, L. S., Hines, M. T., Cordes, R. T., Knowles, D. P. & Scoles, G. A. (2009). Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential. Antimicrobial Agents and Chemotherapy, 53 (10), 4327-4332.
83. Sevinc, F., Turgut, K., Sevinc, M., Ekici O. D., Coskun, A., Koc, Y., Erol, M. & Ica, A. (2007). Therapeutic and prophylactic efficacy of imidocarb dipropionate on experimental Babesia ovis infection of lambs. Veterinary Parasitology, 149 (1-2), 65-71.
84. Shen, Y., Gao, J., Xu, K., Xue, L., Zhang, Y., Shi, B., Li, D., Wei, X. & Selichi H. (1997). Babesiasis in Nanjing area, China. Tropical Animal Health and Production, 29 (4), 19S-22S.
85. Simões, P. B., Cardoso, L., Araújo, M., Yisaschar-Mekuzas, Y. & Baneth, G. (2011). Babesiosis due to the canine Babesia microti-like small piroplasm in dogs-first report from Portugal and possible vertical transmission. Parasites & Vectors, 4 (1), 1-6.
86. Ulusan, M., Varol, K., Ekinci, G., Çakır Bayram, L., Keleş, İ., Onmaz, A. C. & Güneş, V. (2016). Bir koyun sürüsünde imidokarb uygulamasına bağlı kalp kası hasarının biyobelirteçler ışığında değerlendirilmesi: 5 vaka. Kocatepe Veterinary Journal, 9 (2), 135-139.
87. Uslu, M., Canbar, R. & Yazar, E. (2021). Genel tedavi, in: Merkep (Eşek) El Kitabı, Eds: Çizmeci SÜ, Alaşahan S, Nobel yayınevi, Ankara, Türkiye, pp:147-172.
88. Xaxa, L. S. & Kumar, P. (2018). Therapeutic management of E. canis in dog. International Journal of Current Microbiology and Applied Sciences, 7, 3335-3339.
89. Yan, Z., Liu, J., Chen, T., Cheng, Z., Guo, H., Wang, Z. & Wang, Y. (2008). Treatment of Mycoplasma wenyonii infection in cows with imidocarb dipropionate injection-acupuncture. Journal of Acupuncture and Meridian Studies, 1 (2), 143-148.
90. Yazar, E. (2018). Veteriner İlaç ve Aşı A’dan Z’ye. Nobel tıp kitabevleri, İstanbul, Türkiye, pp:120-121.
91. Yazar, E. (2021a). Antiprotozoon tedavi, Veteriner İlaç Rehberi ve Tedavi El Kitabı, Ed: Yazar E, Nobel tıp kitabevleri, İstanbul, Türkiye, pp: 216-223.
92. Yazar, E. (2021b). Köpeklerde Tedavi El Kitabı, Nobel tıp kitabevleri, İstanbul, Türkiye, pp:11-12, 86-100.